Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-034092
Filing Date
2022-06-03
Accepted
2022-06-03 16:40:10
Documents
1
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4043
  Complete submission text file 0001209191-22-034092.txt   5519
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Sanna Bastiano (Reporting) CIK: 0001829069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 22995200